Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33)

This grant solicits applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research.

This grant solicits applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community.

Funding: $300,000 per year 

Duration: 3 years

Research Authority due date: 10 days prior to submission

LOI (encouraged) due dates: 22.3.22, 22.8.22

Full proposal due dates: 22.4.22, 22.9.22